iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) Stock Price Up 0.8% – Still a Buy?

iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE)’s share price shot up 0.8% during mid-day trading on Wednesday . The company traded as high as $31.43 and last traded at $31.30. 12,858 shares were traded during mid-day trading, an increase of 138% from the average session volume of 5,402 shares. The stock had previously closed at $31.06.

iShares LifePath Target Date 2045 ETF Trading Down 0.3 %

The stock’s 50-day moving average price is $31.58 and its 200-day moving average price is $31.61. The company has a market capitalization of $24.25 million, a P/E ratio of 21.45 and a beta of 0.90.

Institutional Trading of iShares LifePath Target Date 2045 ETF

A hedge fund recently bought a new stake in iShares LifePath Target Date 2045 ETF stock. Heck Capital Advisors LLC acquired a new stake in iShares LifePath Target Date 2045 ETF (NYSEARCA:ITDE) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm acquired 869 shares of the company’s stock, valued at approximately $27,000. Heck Capital Advisors LLC owned about 0.27% of iShares LifePath Target Date 2045 ETF as of its most recent SEC filing.

About iShares LifePath Target Date 2045 ETF

The iShares LifePath Target Date 2045 ETF USD (ITDE) is an exchange-traded fund that mostly invests in target date asset allocation. The fund is an actively managed fund-of-funds that invests in equity, fixed income, and money market ETFs using an asset allocation strategy that shifts exposure as the target retirement date approaches.